Skip to main content
SpringerLink
Log in

Hormone Therapy for Transgender Women

  • Chapter
  • First Online:
Gender Confirmation Surgery

  • 966 Accesses

Abstract

Sex steroid hormones play an important role in gender-confirming therapies of transgender women to modify the external physical appearance to align with gender identity. Most transgender women seeking gender-confirming surgeries will be taking gender-confirming sex steroid hormone therapy. Under medical supervision, hormone therapy appears to be safe with very low risk of complications [1]. However, some patients may be receiving hormone therapy without a prescription or routine medical monitoring which may lead to increased risk of complications [2]. Surgeons and physicians and other healthcare providers should understand and recognize the goals of gender-affirming hormone therapy and potential pitfalls during the pre-, peri-, and postoperative period of gender-confirming surgery which will be covered in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weinand JD, Safer JD. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol. 2015 Jun;2(2):55–60.

    PubMed  PubMed Central  Google Scholar 

  2. Seal LJ, Franklin S, Richards C, Shishkareva A, Sinclaire C, Barrett J. Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens. J Clin Endocrinol Metab. 2012 Dec;97(12):4422–8.

    Article  CAS  Google Scholar 

  3. Weinand JD, Safer JD. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol. 2015 Jun;2(2):55–60.

    Google Scholar 

  4. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009 Sep;94(9):3132–54.

    Article  CAS  Google Scholar 

  5. Tangpricha V, den den Heijer M, Oestrogen and anti-androgen therapy for transgender. Lancet Diabetes Endocrinol, 5, 4, 291–300.

    Google Scholar 

  6. Berli JU, Knudson G, Fraser L, Tangpricha V, Ettner R, Ettner FM, Safer JD, Graham J, Monstrey S, Schechter L. What surgeons need to know about gender confirmation surgery when providing Care for Transgender Individuals a Review. JAMA Surg. 2017;152(4):394–400. https://doi.org/10.1001/jamasurg.2016.5549.

    Article  PubMed  Google Scholar 

  7. Irwig MS. Persistent sexual and nonsexual adverse effects of finasteride in younger men. Sex Med Rev. January 2014;2(1):24–35.

    Article  Google Scholar 

  8. Tangpricha V, den Heijer M. Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol. 2017 Apr;5(4):291–300.

    Article  CAS  Google Scholar 

  9. Seal LJ, Franklin S, Richards C, Shishkareva A, Sinclaire C, Barrett J. Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens. J Clin Endocrinol Metab. 2012;97:4422–8.

    Article  CAS  Google Scholar 

  10. Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB. Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertil Steril. 2010;93:1267–72.

    Article  Google Scholar 

  11. Asscheman H, T’Sjoen G, Lemaire A, et al. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia. 2014;46:791–5.

    Article  CAS  Google Scholar 

  12. Ribeiro DD, Lijfering WM, Rosendaal FR, Cannegieter SC. Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors. J Thromb Haemost. 2016;14:1572–8.

    Article  CAS  Google Scholar 

  13. Gooren LJ, T’Sjoen G. Endocrine treatment of aging transgender people. Rev Endocr Metab Disord. 2018 Sep;19(3):253–62.

    Article  CAS  Google Scholar 

  14. Van Caenegem E, Taes Y, Wierckx K, et al. Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone. 2013;54:92–7.

    Article  Google Scholar 

  15. van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol. 1998;48:347–54.

    Article  Google Scholar 

  16. Fischer EM, Patsch J, Muschitz C, Becker S, Resch H. Severe osteoporosis with multiple vertebral fractures after gender reassignment therapy – is it male or female osteoporosis? Gynecol Endocrinol. 2011;27:341–4.

    Article  Google Scholar 

  17. Wierckx K, Van Caenegem E, Schreiner T, et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. Sex Med. 2014;11:1999–011.

    Article  CAS  Google Scholar 

  18. Braun H, Nash R, Tangpricha V, Brockman J, Ward K, Goodman M. Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev. 2017 May 9;39:1–15. https://doi.org/10.1093/epirev/mxw003 [Epub ahead of print].

  19. GR B, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2015 Jan;149(1):191–8.

    Article  Google Scholar 

  20. Dhejne C, Van Vlerken R, Heylens G, Arcelus J. Mental health and gender dysphoria: a review of the literature. Int Rev Psychiatry. 2016;28(1):44–57.

    Google Scholar 

  21. Blosnich JR, Brown GR, Wojcio S, Jones KT, Bossarte RM. Mortality among veterans with transgender-related diagnoses in the veterans health administration, FY2000–2009. LGBT Health. 2014 Dec;1(4):269–76.

    Google Scholar 

  22. Gómez-Gil E, Zubiaurre-Elorza L, Esteva I, et al. Hormone-treated transsexuals report less social distress, anxiety and depression. Psychoneuroendocrinology. 2012;37:662–70.

    Google Scholar 

  23. Murad MH, Elamin MB, Garcia MZ, et al. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol. 2010;72:214–31.

    Article  Google Scholar 

  24. Coleman E, Bockting W, Botzer M, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13:165–232.

    Article  Google Scholar 

  25. Feldman J, Brown GR, Deutsch MB, Hembree W, Meyer W, Meyer-Bahlburg HFL, Tangpricha V, T’Sjoen G, Safer JD. Priorities for transgender medical and healthcare research. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):180–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Emory University of Medicine, Atlanta Medical Center, Atlanta, GA, USA

    Vin Tangpricha

  2. Center for Transgender Medicine and Surgery, Mount Sinai Health System, New York, NY, USA

    Joshua D. Safer

Authors
  1. Vin Tangpricha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joshua D. Safer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Plastic Surgery, The Center for Gender Confirmation Surgery Weiss Memorial Hospital, Chicago, IL, USA

    Loren S. Schechter

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tangpricha, V., Safer, J.D. (2020). Hormone Therapy for Transgender Women. In: Schechter, L. (eds) Gender Confirmation Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-29093-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-29093-1_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-29092-4

  • Online ISBN: 978-3-030-29093-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation